Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

